ELEVANCE HEALTH INC (1ANTM.MI) Fundamental Analysis & Valuation
BIT:1ANTM • US0367521038
Current stock price
315.5 EUR
+11.3 (+3.71%)
Last:
This 1ANTM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1ANTM.MI Profitability Analysis
1.1 Basic Checks
- In the past year 1ANTM was profitable.
- In the past year 1ANTM had a positive cash flow from operations.
- 1ANTM had positive earnings in each of the past 5 years.
- 1ANTM had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of 1ANTM (4.51%) is better than 78.13% of its industry peers.
- 1ANTM's Return On Equity of 12.59% is fine compared to the rest of the industry. 1ANTM outperforms 68.75% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 5.60%, 1ANTM is in line with its industry, outperforming 53.13% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for 1ANTM is in line with the industry average of 5.91%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROIC | 5.6% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
1.3 Margins
- The Profit Margin of 1ANTM (2.84%) is better than 65.63% of its industry peers.
- In the last couple of years the Profit Margin of 1ANTM has declined.
- 1ANTM's Operating Margin of 4.35% is in line compared to the rest of the industry. 1ANTM outperforms 56.25% of its industry peers.
- In the last couple of years the Operating Margin of 1ANTM has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A |
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
2. 1ANTM.MI Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ANTM is destroying value.
- The number of shares outstanding for 1ANTM has been reduced compared to 1 year ago.
- The number of shares outstanding for 1ANTM has been reduced compared to 5 years ago.
- 1ANTM has a worse debt/assets ratio than last year.
2.2 Solvency
- 1ANTM has a debt to FCF ratio of 8.63. This is a slightly negative value and a sign of low solvency as 1ANTM would need 8.63 years to pay back of all of its debts.
- The Debt to FCF ratio of 1ANTM (8.63) is comparable to the rest of the industry.
- A Debt/Equity ratio of 0.71 indicates that 1ANTM is somewhat dependend on debt financing.
- The Debt to Equity ratio of 1ANTM (0.71) is better than 81.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Altman-Z | N/A |
ROIC/WACC0.66
WACC8.46%
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. 1ANTM.MI Growth Analysis
3.1 Past
- The earnings per share for 1ANTM have decreased strongly by -11.71% in the last year.
- The Earnings Per Share has been growing by 11.17% on average over the past years. This is quite good.
- 1ANTM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.96%.
- Measured over the past years, 1ANTM shows a quite strong growth in Revenue. The Revenue has been growing by 11.14% on average per year.
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
3.2 Future
- Based on estimates for the next years, 1ANTM will show a small growth in Earnings Per Share. The EPS will grow by 7.64% on average per year.
- 1ANTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.62% yearly.
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. 1ANTM.MI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 11.95, which indicates a very decent valuation of 1ANTM.
- 1ANTM's Price/Earnings ratio is a bit cheaper when compared to the industry. 1ANTM is cheaper than 75.00% of the companies in the same industry.
- When comparing the Price/Earnings ratio of 1ANTM to the average of the S&P500 Index (24.88), we can say 1ANTM is valued rather cheaply.
- A Price/Forward Earnings ratio of 13.42 indicates a correct valuation of 1ANTM.
- Based on the Price/Forward Earnings ratio, 1ANTM is valued a bit cheaper than 65.63% of the companies in the same industry.
- 1ANTM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.95 | ||
| Fwd PE | 13.42 |
4.2 Price Multiples
- 1ANTM's Enterprise Value to EBITDA ratio is in line with the industry average.
- 1ANTM's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 1ANTM is more expensive than 65.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.89 | ||
| EV/EBITDA | 10.45 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)1.07
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
5. 1ANTM.MI Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.79%, 1ANTM has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.96, 1ANTM pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.90, 1ANTM has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.79% |
5.2 History
- On average, the dividend of 1ANTM grows each year by 15.34%, which is quite nice.
Dividend Growth(5Y)15.34%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- 1ANTM pays out 27.56% of its income as dividend. This is a sustainable payout ratio.
- 1ANTM's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.56%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
1ANTM.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1ANTM (1/7/2026, 7:00:00 PM)
315.5
+11.3 (+3.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap70.12B
Revenue(TTM)194.82B
Net Income(TTM)5.53B
Analysts73.57
Price Target335.28 (6.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.79% |
Yearly Dividend5.64
Dividend Growth(5Y)15.34%
DP27.56%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.38%
Min EPS beat(2)-2.26%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)5.76%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)5
Avg EPS beat(8)0.95%
EPS beat(12)8
Avg EPS beat(12)1.31%
EPS beat(16)11
Avg EPS beat(16)1.68%
Revenue beat(2)2
Avg Revenue beat(2)0.95%
Min Revenue beat(2)0.45%
Max Revenue beat(2)1.45%
Revenue beat(4)3
Avg Revenue beat(4)1.37%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)4.3%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)7
Avg Revenue beat(12)1%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)5.44%
PT rev (3m)5.44%
EPS NQ rev (1m)-24.94%
EPS NQ rev (3m)-24.94%
EPS NY rev (1m)0.31%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)0.32%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.95 | ||
| Fwd PE | 13.42 | ||
| P/S | 0.42 | ||
| P/FCF | 21.89 | ||
| P/OCF | 16.74 | ||
| P/B | 1.85 | ||
| P/tB | 19.51 | ||
| EV/EBITDA | 10.45 |
EPS(TTM)26.41
EY8.37%
EPS(NY)23.51
Fwd EY7.45%
FCF(TTM)14.41
FCFY4.57%
OCF(TTM)18.85
OCFY5.97%
SpS754.6
BVpS170.24
TBVpS16.17
PEG (NY)N/A
PEG (5Y)1.07
Graham Number318.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.51% | ||
| ROE | 12.59% | ||
| ROCE | 7.32% | ||
| ROIC | 5.6% | ||
| ROICexc | 6.06% | ||
| ROICexgc | 10.93% | ||
| OM | 4.35% | ||
| PM (TTM) | 2.84% | ||
| GM | N/A | ||
| FCFM | 1.91% |
ROA(3y)5.45%
ROA(5y)5.58%
ROE(3y)15.32%
ROE(5y)15.33%
ROIC(3y)6.9%
ROIC(5y)7.19%
ROICexc(3y)7.45%
ROICexc(5y)7.72%
ROICexgc(3y)13.9%
ROICexgc(5y)14.63%
ROCE(3y)9.03%
ROCE(5y)9.4%
ROICexgc growth 3Y-5.49%
ROICexgc growth 5Y-3.16%
ROICexc growth 3Y-5.02%
ROICexc growth 5Y-2.23%
OM growth 3Y-7.78%
OM growth 5Y-4.45%
PM growth 3Y-8.42%
PM growth 5Y-6.01%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 8.63 | ||
| Debt/EBITDA | 3.13 | ||
| Cap/Depr | 74.45% | ||
| Cap/Sales | 0.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 48.59% | ||
| Profit Quality | 67.25% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACC8.46%
ROIC/WACC0.66
Cap/Depr(3y)77.74%
Cap/Depr(5y)81.03%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.76%
Profit Quality(3y)103.66%
Profit Quality(5y)128.32%
High Growth Momentum
Growth
EPS 1Y (TTM)-11.71%
EPS 3Y8.28%
EPS 5Y11.17%
EPS Q2Q%-27.96%
EPS Next Y-8.14%
EPS Next 2Y-8.99%
EPS Next 3Y-1.44%
EPS Next 5Y7.64%
Revenue 1Y (TTM)11.96%
Revenue growth 3Y8.44%
Revenue growth 5Y11.14%
Sales Q2Q%12%
Revenue Next Year13.09%
Revenue Next 2Y8.09%
Revenue Next 3Y6.88%
Revenue Next 5Y4.62%
EBIT growth 1Y-10.69%
EBIT growth 3Y0%
EBIT growth 5Y6.19%
EBIT Next Year-2.04%
EBIT Next 3Y0.56%
EBIT Next 5Y8.31%
FCF growth 1Y-54.88%
FCF growth 3Y-14.89%
FCF growth 5Y-2.08%
OCF growth 1Y-48.85%
OCF growth 3Y-11.78%
OCF growth 5Y-1.08%
ELEVANCE HEALTH INC / 1ANTM.MI Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ELEVANCE HEALTH INC (1ANTM.MI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1ANTM.MI.
What is the valuation status of ELEVANCE HEALTH INC (1ANTM.MI) stock?
ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (1ANTM.MI). This can be considered as Fairly Valued.
How profitable is ELEVANCE HEALTH INC (1ANTM.MI) stock?
ELEVANCE HEALTH INC (1ANTM.MI) has a profitability rating of 4 / 10.
What is the financial health of ELEVANCE HEALTH INC (1ANTM.MI) stock?
The financial health rating of ELEVANCE HEALTH INC (1ANTM.MI) is 3 / 10.
What is the expected EPS growth for ELEVANCE HEALTH INC (1ANTM.MI) stock?
The Earnings per Share (EPS) of ELEVANCE HEALTH INC (1ANTM.MI) is expected to decline by -8.14% in the next year.